AMP 2017
November 15, 2017
Medical Japan 2018
December 4, 2017

Press release

Qvella announced today that it has completed US$20M in Series B Financing to Fund Clinical Trials,
On-going Research, Team Expansion, and Manufacturing Buildup. New strategic investor bioMérieux will explore collaborative opportunities around Qvella’s Field Activated Sample Treatment (FAST) technology in complementary markets.

Learn More

Leave a Reply

Your email address will not be published. Required fields are marked *